Supporting the Recovery Needs of Patients Following Intensive Care

Overview

Recovery for intensive care survivors is limited by ongoing problems with walking, strength, fatigue, mental distress and cognitive morbidity known as 'Post Intensive Care Syndrome'. There has been increasing interest in ways that clinicians can support patients in their post ICU recovery. The investigators are undertaking a co design approach to informing the design of a recovery pathway for patients who have been admitted to the intensive care to support them in their return to home, family and working responsibilities.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: July 2022

Detailed Description

This project will aim to involve ~ 20 past ICU patient/family members and ~20 health professionals to participate in a co-design approach to examine the recovery needs and resources that are required to support patients after leaving hospital. Using an experience based co design methodology three 2-hour workshops will be run with the first workshop involving patients/family members, the second involving healthcare professionals to separately gain thoughts and perspectives, and then the final workshop which will be combined to identify and problem solve priority resources and solutions.

Interventions

  • Other: Former ICU patient and caregiver workshops
    • In depth interviews and workshops will be conducted with individuals enrolled in the study.
  • Other: Health care professional workshops
    • In depth interviews and workshops will be conducted with individuals enrolled in the study.

Arms, Groups and Cohorts

  • Interviews: Past ICU patients and caregivers
    • Former ICU patients and their families that meet the following criteria: Adults > 18 years and above who required at least 48 hours of invasive mechanical ventilation and were in the ICU at least 4 days with an ICU admission in the past five years; and able to participate in a workshop in English.
  • Interviews: Health care professionals
    • Active working health professionals with prior experience working directly in the ICU setting and/or care for ICU patients in their own clinical rea (acute, subacute and/or community settings).

Clinical Trial Outcome Measures

Primary Measures

  • Lived experiences and opinions
    • Time Frame: 3 months
    • Capability Opportunity Motivation Barriers and Theoretical Domains Framework will be used to interpret qualitative data from the workshops and interviews.

Participating in This Clinical Trial

Inclusion Criteria

  • Hospitalized adults, aged 18 years or over – Admitted to the ICU requiring invasive mechanical ventilation for > 48 hours and remain in the ICU for a minimum of four days – Living at home before the current admission (not in a facility and/or no fixed abode) Exclusion Criteria:

  • Non-English speaking (insufficient English language skills to read and understand questionnaires and patient information consent form) – Pre-existing documented cognitive impairment – Spinal cord injury or other primary neuromuscular disease – New lower limb fracture with altered weight bearing status – Expected survival < 3 months according to the treating medical team – Active substance abuse or psychosis – Lack of access to telephone / computer or inability to use these resources independently (which would impact on ability to complete the intervention) – Pregnancy – Suicidality – Incarcerated – Cardiac surgery within this ICU admission (as these patients routinely receive a standard outpatient rehabilitation through cardiac rehabilitation) – Poor premorbid mobility defined as < 10 metres ambulation +/- gait aid independently

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Melbourne
  • Provider of Information About this Clinical Study
    • Principal Investigator: Selina M Parry, Cardiorespiratory Team Lead, Department of Physiotherapy – University of Melbourne

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.